<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00233792</url>
  </required_header>
  <id_info>
    <org_study_id>P99-6301</org_study_id>
    <nct_id>NCT00233792</nct_id>
  </id_info>
  <brief_title>FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent</brief_title>
  <official_title>An Evaluation of the Sirolimus Coated Modified BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo or Restenotic Native Coronary Artery Lesions.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cordis Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cordis Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single center, non-randomized study. Patients will be treated with the sirolimus
      coated Bx VELOCITY Balloon-Expandable Stent mounted on the Raptor OTW SDS. Patients will have
      a repeat angiography at four months and will be followed for twelve months post-procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center, non-randomized study of the Bx VELOCITY Balloon-Expandable Stent
      coated with sirolimus (140Âµg/cm2) and formulated for fast or slow release. The sirolimus
      coated stent is mounted on the Raptor OTW SDS. Approximately 30 patients with de novo or
      restenotic native coronary artery lesions &lt;=18mm in length and &gt;=3.0 to &gt;=3.5 mm in diameter
      by visual estimate who meet all eligibility criteria will be treated with the sirolimus
      coated Bx VELOCITY stent(s). Patients will be followed for five years post-procedure and will
      have a repeat angiography at 4 months, 12 months, 24 months, and 48 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 1999</start_date>
  <completion_date type="Actual">March 2005</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of in-stent percent diameter stenosis (%DS) measured by quantitative coronary angiography.</measure>
    <time_frame>post procedure and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of lesion morphology by intravascular ultrasound (IVUS).</measure>
    <time_frame>post procedure and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel failure (TVF).</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>sirolimus coated Bx VELOCITY stent - fast release</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>sirolimus coated Bx VELOCITY stent - slow release</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sirolimus coated Bx VELOCITY stent - fast release</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sirolimus coated Bx VELOCITY stent - slow release</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosis of angina pectoris as defined by Canadian Cardiovascular Society
             Classification (CCS) or a positive ischemia study;

          2. Single de novo or restenotic lesion requiring treatment in a major native coronary
             artery;

          3. Target lesion is &lt;=18mm in length (visual estimate);

          4. Target lesion is &gt;=3.0mm and &lt;=3.5mm in diameter (visual estimate);

          5. Target lesion stenosis is &gt;50% and &lt;100% (visual estimate);

        Exclusion Criteria:

          1. A Q-wave or non-Q-wave myocardial infarction within the preceding 72 hours unless the
             CK and CK-MB enzymes are back to normal;

          2. Unprotected left main coronary disease with &gt;=50% stenosis;

          3. Have an ostial target lesion;

          4. Angiographic evidence of thrombus within target lesion;

          5. Calcified lesions which cannot be successfully predilated;

          6. Ejection fraction &lt;=30%;

          7. Target lesion involves bifurcation (either stenosis of both main vessel and major
             branch or stenosis of just major branch);

          8. Totally occluded vessel;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eduardo J Sousa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Dante Pazzanese of Cardiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Dante Pazzanese of Cardiology</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04012-909</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, Feres F, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation. 2003 Jan 28;107(3):381-3.</citation>
    <PMID>12551858</PMID>
  </results_reference>
  <results_reference>
    <citation>Sousa JE, Costa MA, Abizaid A, Feres F, Seixas AC, Tanajura LF, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW, Sousa AG. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation. 2005 May 10;111(18):2326-9. Epub 2005 Apr 25.</citation>
    <PMID>15851603</PMID>
  </results_reference>
  <results_reference>
    <citation>Aoki J, Abizaid AC, Serruys PW, Ong AT, Boersma E, Sousa JE, Bruining N. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol. 2005 Nov 1;46(9):1670-6. Epub 2005 Oct 10.</citation>
    <PMID>16256867</PMID>
  </results_reference>
  <results_reference>
    <citation>Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM, Seixas AC, Staico R, Mattos LA, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001 Jan 16;103(2):192-5.</citation>
    <PMID>11208675</PMID>
  </results_reference>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 4, 2005</study_first_submitted>
  <study_first_submitted_qc>October 5, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2005</study_first_posted>
  <last_update_submitted>October 11, 2007</last_update_submitted>
  <last_update_submitted_qc>October 11, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sirolimus</mesh_term>
    <mesh_term>Everolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

